Reports for MINT PHARMACEUTICALS INC

Company Name

MINT PHARMACEUTICALS INC

Totals

Shortage reports

132

Actual shortage: 30 (23%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 102 (77%)

Discontinuation Reports

29

To be discontinued: 0 (0%)
Discontinued: 29 (100%)
Reversed: 0 (0%)

Late reports

33 (20%)

Overdue reports

7 (23%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-19 2024-03-19 222750
MINT-ATORVASTATIN 40MG TABLET Resolved 2024-01-29 2024-01-30 217696
MINT-ATORVASTATIN 20MG TABLET Resolved 2024-01-29 2024-01-30 217693
MINT-ATORVASTATIN 10MG TABLET Resolved 2024-01-29 2024-01-30 217690
MINT-TOPIRAMATE 200MG TABLET Actual shortage 2024-01-29 2024-01-29 217687
MINT-TOPIRAMATE 100MG TABLET Actual shortage 2024-01-29 2024-01-29 217684
MINT-TOPIRAMATE 25MG TABLET Resolved 2024-01-29 2024-03-26 217681
MINT-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-26 2024-01-26 217396
MINT-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-03-26 217393
MINT-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-03-26 217390
MINT-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-26 2024-01-26 217387
MINT-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-26 2024-01-26 217384
MINT-PRAVASTATIN 40MG TABLET TABLET Resolved 2024-01-26 2024-03-26 217381
MINT-PRAVASTATIN 20MG TABLET TABLET Actual shortage 2024-01-26 2024-03-25 217378
MINT-PRAVASTATIN 10MG TABLET TABLET Resolved 2024-01-26 2024-03-26 217375
MINT-LETROZOLE 2.5MG TABLET Actual shortage 2024-01-26 2024-01-26 217372
MINT-ANASTROZOLE 1MG TABLET Resolved 2024-01-26 2024-03-26 217369
MINT-ALENDRONATE 70.0MG TABLET Actual shortage 2024-01-26 2024-01-26 217366
MINT-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-24 2024-01-09 199939
MINT-DICLOFENAC 0.1% SOLUTION Actual shortage 2023-03-27 2023-09-27 188045

Showing 1 to 20 of 132

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-CLOPIDOGREL 75MG TABLET Discontinued 2018-08-16 2018-08-17 58286
MINT-CLOPIDOGREL 75MG TABLET Discontinued 2018-08-16 2018-08-17 58283
MINT-RIVASTIGMINE 4.5MG CAPSULE Discontinued 2017-06-21 2017-07-01 13565
MINT-RIVASTIGMINE 1.5MG CAPSULE Discontinued 2017-06-21 2017-07-01 13562
MINT-RIVASTIGMINE 6MG CAPSULE Discontinued 2017-06-21 2017-07-01 13559
MINT-RIVASTIGMINE 3MG CAPSULE Discontinued 2017-06-21 2017-07-01 13556
MINT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13553
MINT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13544
MINT-ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13540

Showing 21 to 29 of 29